印度臍帶血銀行服務市場：依服務類型、組件、儲存類型、應用、最終用戶、地區、機會和預測，2018-2032年

印度臍帶血銀行服務市場規模預計將從2024年的1.3255億美元成長到2032年的2.4084億美元，預測期內（2025-2032年）的年複合成長率為 7.75%。

由於最近的技術進步和對高效解決方案的需求不斷增加，印度臍帶血銀行服務市場經歷顯著成長。推動該國市場擴張的主要因素之一是由於久坐的生活方式和不斷變化的環境條件導致大多數人口的生殖功能下降。圍繞女性不孕症的禁忌現在解除了，隨著意識在全國範圍內傳播，人們可以更自由地利用這些醫療選擇。此外，政府對醫療保健基礎設施的投資、技術進步以及對尖端解決方案的需求不斷成長也增強了市場的成長軌跡。醫療保健領域的快速發展，尤其是亞太地區的快速發展，提供了良好的前景。例如，印度最大、最負盛名的幹細胞銀行 LifeCell International Limited 於2023年 11月以全球最低價推出了一項突破性的幹細胞銀行解決方案。這項突破性的產品以臍帶血幹細胞為基礎，過去 25年來已在全球成功完成超過 30,000 例移植手術。此次發布恰逢全球慶祝臍帶血幹細胞治療25週年。

本報告研究了印度臍帶血銀行服務市場，並概述了市場及其主要細分市場，包括服務類型、組件、儲存類型、應用、最終用戶、區域趨勢和公司概況。

目錄

第1章 專案範圍與定義

第2章 研究方法

第3章 執行摘要

第4章 印度臍帶血銀行服務市場的前景，2018年～2032年

• 市場規模分析及預測
• 市場佔有率分析及預測
• 2024年市場地圖分析
  • 依服務類型
  • 依組件
  • 依儲存類型
  • 依用途
  • 依最終用戶
  • 依地區

第5章 需求與供給分析

第6章 波特五力分析

第7章 PESTLE 分析

第8章 定價分析

第9章 市場動態

第10章 市場趨勢與發展

第11章 案例研究

第12章 競爭格局

• 五大市場領導者的競爭矩陣
• 五大公司的SWOT分析
• 市場前十大主要公司的狀況
  • Cordlife India Private Limited
  • LifeCell International Private Limited
  • Cryoviva Biotech India Private Limited
  • StemCyte India Therapeutics Private Limited
  • Reliance Life Sciences Private Limited
  • BabyCell India Private Limited
  • CReATe Cord Blood Bank
  • CryoVault Biotech India Private Limited
  • NovaCord Stem Cell Bank
  • ReeLabs Stem Cell Bank

第13章 策略建議

第14章 關於調查公司/免責聲明

India cord blood banking services market is projected to witness a CAGR of 7.75% during the forecast period FY2025-FY2032, growing from USD 132.55 million in FY2024 to USD 240.84 million in FY2032.

India market for cord blood banking services has grown significantly because of recent advancements in technologies and the growing demand for efficient solutions. One of the primary factors propelling market expansions in the country is most of the population's declining reproductive health owing to the sedentary lifestyles and shifting environmental conditions. The taboo that is still associated with infertility issues in women are now dissolving, and people are more freely availing these medical options as awareness spreads more around the country. Furthermore, the market's growth trajectory is being reinforced by government investments in healthcare infrastructure, advancements in technology, and the growing demand for cutting-edge solutions. Rapid advancements in healthcare, particularly in Asia-Pacific, present lucrative prospects. For example, the largest and most reputable stem cell bank in India, LifeCell International Limited, unveiled a revolutionary stem cell banking solution in November 2023 at the lowest cost in the world. The key component of this novel product is umbilical cord blood stem cells, which have been utilized in more than 30,000 successful transplants globally over the previous 25 years. This launch coincides with the global observance of the 25th anniversary of umbilical cord blood stem cell treatments.

Scientific Innovations Boosting Market Growth

One of the main factors propelling the growth of India cord blood banking services market is the advancements in stem cell research. The scientific community has advanced our knowledge of the therapeutic potential of stem cells, particularly those present in cord blood, over the years. Numerous illnesses, including leukemia, sickle cell anemia, and even some neurological disorders, can be treated with stem cells. Expectant parents are interested in the increasing amount of evidence that supports the clinical use of cord blood stem cells in immunotherapy, gene therapy, and regenerative medicine. Since cord blood storage may one day lead to life-saving treatments, this increase in scientific support has increased its appeal. As a result, more families opt to store their newborn's cord blood, fostering the growth of cord blood banking services in India. StemCyte India Therapeutics Pvt. Ltd. has adopted a hybrid banking model that combines private and public banking. This model enhances sustainability and expands the potential for stem cell utilization, making it a comprehensive approach to cord blood banking.

Improvements in Healthcare Infrastructure Boosting Market Growth

An important factor driving the expansion of the cord blood banking market in India is the ongoing development of the country's healthcare system. The emergence of cutting-edge healthcare facilities, such as clinics, hospitals, and private healthcare providers offering specialized services, has made cord blood banking more widely available. The safe collection, processing, and storage of cord blood is guaranteed by the growing availability of cutting-edge medical technologies. Additionally, the market's consumers have grown as healthcare services have expanded in both urban and rural locations. The need for cord blood banking services rises as more healthcare facilities and hospitals incorporate it into their services. Moreover, the government's investment in healthcare infrastructure has improved public and private partnerships, providing better healthcare delivery, which indirectly boosts the awareness and uptake of cord blood banking services. For instance, in October 2023, the Singapore Exchange-listed Cordlife Group Limited established its Indian affiliate - Cordlife Sciences India Pvt Ltd, an advanced diagnostic laboratory in Kolkata. The purpose of this new facility is to serve as a testing center for Cordlife India, meeting the medical needs of the company's current stem cell banking customers and their families as well as those of surrounding patients, medical professionals, and doctors.

Government Initiatives Fueling the Market Growth

Government initiatives and support have been an important factor in the growth of the India cord blood banking services market. Indian government's focus on biotechnology and healthcare is creating a conducive environment for the expansion of stem cell-based services, including cord blood banking. Various government-backed programs and policies are aimed at boosting the biotechnology sector, with a specific focus on stem cell research and applications. Additionally, the government's efforts in spreading awareness about stem cell therapies have enhanced public interest in preserving cord blood for future medical use. Initiatives such as funding for research, collaborations with international biotech firms, and regulatory frameworks to ensure ethical practices are further accelerating market growth. Moreover, government support in improving healthcare accessibility, funding public awareness campaigns, and encouraging investment in stem cell technology have all contributed to making cord blood banking services more available and affordable to the Indian population. For example, the Indian government enhanced stem cell research in February 2022, by utilizing a number of departments and institutions. National funding organizations including the Department of Biotechnology (DBT), the Department of Science and Technology (DST), and the Indian Council of Medical Research (ICMR) provided assistance for both basic and clinical research as part of this endeavour. In addition to supporting industrial activities in India, these measures have resulted in the construction of state-of-the-art facilities at over 40 prestigious health research and educational institutes.

Future Market Scenario (FY2025 - FY2032F)

Many factors claim the growth of India cord blood banking services market. Technological advancements give faster and more accurate results leading us to early diagnosis. Opportunity also lies in the increasing number of fertility concerns that the population is facing today. Promising initiatives of our government that provide healthcare infrastructure, funds to carry on research and development on a large scale, and a reliable distribution channel that ensures the solution reaches everyone is testimonial. For instance, from primary healthcare facilities to sophisticated tertiary care hospitals, India currently has a vast healthcare infrastructure. One of the biggest healthcare systems in the world is expected to grow because of increased public and private sector investment. To increase access to high-quality healthcare for a larger portion of the population, developers are currently collaborating with healthcare providers to build cutting-edge facilities in tier 2 and tier 3 cities as well as metropolitan areas.

Key Players Landscape and Outlook

Key players in the cord blood banking services industry utilize strategies such as mergers, acquisitions, partnerships, and new product launches to improve their services and competitiveness. Such efforts will propel significant growth in the market, allowing big-cap industry players to increase their presence and, therefore, find new opportunities in this market.

For instance, to increase shareholder value, Cryo-Cell International, Inc. announced in March 2024 that it will spin off its subsidiary, Celle Corp. This can positively impact the cord blood banking services in India by being able to expand further and bring cutting-edge technology which will open the room for this market to grow.

Recent advancements indicate that stem cell research is a top focus in India. The US-based company StemCures stated in May 2023 that it will invest a substantial $54 million to build the largest stem cell production facility in India in Hyderabad. Furthermore, Stempeutics Research Pvt. Ltd. has achieved great progress by bringing India's first allogeneic stem cell therapy, Stempeucel, to market. This ground-breaking treatment is intended to restore blood flow in ischemic areas, giving patients all over the world hope.

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Executive Summary

4. India Cord Blood Banking Services Market Outlook, FY2018-FY2032F

• 4.1. Market Size Analysis & Forecast
  • 4.1.1. By Value
• 4.2. Market Share Analysis & Forecast
  • 4.2.1. By Service Type
    • 4.2.1.1. Sample Preservation and Storage
    • 4.2.1.2. Sample Analysis
    • 4.2.1.3. Sample Processing
    • 4.2.1.4. Sample Collection and Transportation
  • 4.2.2. By Component
    • 4.2.2.1. Cord Blood
    • 4.2.2.2. Cord Tissue
  • 4.2.3. By Storage Type
    • 4.2.3.1. Public Cord Blood Banks
    • 4.2.3.2. Private Cord Blood Banks
  • 4.2.4. By Application
    • 4.2.4.1. Cancer
    • 4.2.4.2. Blood Disorders
    • 4.2.4.3. Fertility Disorders
    • 4.2.4.4. Immune Disorders
    • 4.2.4.5. Others
  • 4.2.5. By End-user
    • 4.2.5.1. Hospitals
    • 4.2.5.2. Research Institutes and Academic Centers
    • 4.2.5.3. Fertility Clinics
    • 4.2.5.4. Others
  • 4.2.6. By Region
    • 4.2.6.1. North
    • 4.2.6.2. South
    • 4.2.6.3. East
    • 4.2.6.4. West and Central
  • 4.2.7. By Company Market Share Analysis (Top 5 Companies and Others - By Value, FY2024)
• 4.3. Market Map Analysis, FY2024
  • 4.3.1. By Service Type
  • 4.3.2. By Component
  • 4.3.3. By Storage Type
  • 4.3.4. By Application
  • 4.3.5. By End-user
  • 4.3.6. By Region

All segments will be provided for all regions and countries covered

5. Demand Supply Analysis

6. Porter's Five Forces Analysis

7. PESTLE Analysis

8. Pricing Analysis

9. Market Dynamics

• 9.1. Market Drivers
• 9.2. Market Challenges

10. Market Trends and Developments

11. Case Studies

12. Competitive Landscape

• 12.1. Competition Matrix of Top 5 Market Leaders
• 12.2. SWOT Analysis for Top 5 Players
• 12.3. Key Players Landscape for Top 10 Market Players
  • 12.3.1. Cordlife India Private Limited
    • 12.3.1.1. Company Details
    • 12.3.1.2. Key Management Personnel
    • 12.3.1.3. Products and Services
    • 12.3.1.4. Financials (As Reported)
    • 12.3.1.5. Key Market Focus and Geographical Presence
    • 12.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisition
  • 12.3.2. LifeCell International Private Limited
  • 12.3.3. Cryoviva Biotech India Private Limited
  • 12.3.4. StemCyte India Therapeutics Private Limited
  • 12.3.5. Reliance Life Sciences Private Limited
  • 12.3.6. BabyCell India Private Limited
  • 12.3.7. CReATe Cord Blood Bank
  • 12.3.8. CryoVault Biotech India Private Limited
  • 12.3.9. NovaCord Stem Cell Bank
  • 12.3.10. ReeLabs Stem Cell Bank

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

13. Strategic Recommendations

14. About Us and Disclaimer

List of Tables

• Table 1. Competition Matrix of Top 5 Market Leaders
• Table 2. Mergers & Acquisitions/ Joint Ventures (If Applicable)
• Table 3. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

• Figure 1. India Cord Blood Banking Services Market, By Value, In USD Million, FY2018-FY2032F
• Figure 2. India Cord Blood Banking Services Market Share (%), By Service Type, FY2018-FY2032F
• Figure 3. India Cord Blood Banking Services Market Share (%), By Component, FY2018-FY2032F
• Figure 4. India Cord Blood Banking Services Market Share (%), By Storage Type, FY2018-FY2032F
• Figure 5. India Cord Blood Banking Services Market Share (%), By Application, FY2018-FY2032F
• Figure 6. India Cord Blood Banking Services Market Share (%), By End-user, FY2018-FY2032F
• Figure 7. India Cord Blood Banking Services Market Share (%), By Region, FY2018-FY2032F
• Figure 8. By Service Type Map-Market Size (USD Million) & Growth Rate (%), FY2024
• Figure 9. By Component Map-Market Size (USD Million) & Growth Rate (%), FY2024
• Figure 10. By Storage Type Map-Market Size (USD Million) & Growth Rate (%), FY2024
• Figure 11. By Application Map-Market Size (USD Million) & Growth Rate (%), FY2024
• Figure 12. By End-user Map-Market Size (USD Million) & Growth Rate (%), FY2024
• Figure 13. By Region Map-Market Size (USD Million) & Growth Rate (%), FY2024